By Ellen Capon (Drug Target Review)2024-02-21T14:00:23
Many exciting developments are expected to take place in immunotherapy and oncology in the next few years. We had the privilege of discussing the opportunities of various cell therapies with Dr Suresh Nair, Physician in Chief, who elucidates how Lehigh Valley Topper Cancer Institute is directing research towards better treatments, ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2023-11-24T12:06:45
Sponsored by Quantum-Si
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2024-02-08T11:07:39
Sponsored by Samplix ApS
2023-09-27T13:56:39
Sponsored by Euretos
2024-05-07T13:11:19
Sponsored by BellBrook Labs
Site powered by Webvision Cloud